Exclusive: Sinopharm-led consortium plans US$3.3 billion take-private of HK-listed China TCM - sources
Toggle share menu
Advertisement
Exclusive: Sinopharm-led consortium plans US$3.3 billion take-private of HK-listed China TCM - sources
A consortium led by state-owned pharma giant Sinopharm plans to take private China Traditional Chinese Medicine Holdings in a deal that would value the firm at at least US$3.3 billion, said two people with direct knowledge of the matter.
FILE PHOTO: A sign of Sinopharm is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, China September 5, 2020. REUTERS/Tingshu Wang
27 Jan 2021 02:20PM